Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

SailPoint stock tumbles 6% to start 2026 as SAIL traders brace for next catalysts

SailPoint stock tumbles 6% to start 2026 as SAIL traders brace for next catalysts

NEW YORK, Jan 3, 2026, 20:51 ET — Market closed SailPoint, Inc. shares fell 6.3% on Friday, ending the session at $18.95 and giving the identity-security software maker one of its sharpest daily drops in recent weeks, according to Investing.com market data. The move mattered because investors opened 2026 with an uneven appetite for growth, even as the Dow finished higher and the Nasdaq ended roughly flat, a Reuters market report showed. That backdrop tends to amplify swings in recently listed software names that trade on expectations of future subscription growth, rather than near-term profits. SailPoint also sits in a
Kymera Therapeutics (KYMR) stock drops 6.6% to start 2026 as insider sale filing stays in focus

Kymera Therapeutics (KYMR) stock drops 6.6% to start 2026 as insider sale filing stays in focus

NEW YORK, Jan 3, 2026, 20:43 ET — Market closed Kymera Therapeutics shares slid on Friday, ending down 6.6% at $72.76 as the biotech underperformed its sector even as the broader market started 2026 on a mixed note. The move matters because Kymera has been a high-beta biotech name since a sharp rally in December on early trial data for its KT-621 immunology program, leaving the stock sensitive to profit-taking and fresh supply from capital-raising activity. Kymeratx With U.S. markets facing a busy week of economic releases, risk appetite has been uneven and investors have leaned on near-term catalysts —
Novanta stock tumbles 6.6% to start 2026; traders eye Jan. 14 management talks

Novanta stock tumbles 6.6% to start 2026; traders eye Jan. 14 management talks

NEW YORK, January 3, 2026, 20:47 ET — Market closed Novanta Inc. shares fell 6.6% on Friday, closing at $111.14 after touching an intraday low of $110.25, according to data from Twelve Data. Twelve Data The move stood out because it landed on the first trading day of 2026, when many investors were still returning from year-end breaks and liquidity can be thinner. U.S. stocks finished mixed in that session as Treasury yields rose. Reuters “Today is kind of a holiday trading day, lighter volumes, people not engaged normally,” said Jed Ellerbroek, portfolio manager at Argent Capital in St. Louis.
Paymentus stock ends first 2026 session down nearly 10% — what’s behind the sudden drop?

Paymentus stock ends first 2026 session down nearly 10% — what’s behind the sudden drop?

New York, Jan 3, 2026, 20:13 ET — Market closed Paymentus Holdings’ shares tumbled nearly 10% in the first U.S. trading session of 2026, ending Friday at $28.47. The stock traded as low as $28.22 intraday. Finviz The outsized move lands as investors shift positioning ahead of a busy January calendar that can reset interest-rate bets, a key driver for high-growth stocks. The monthly jobs report due Jan. 9 and the consumer price index on Jan. 13 are among the headline events, Reuters reported. Reuters “The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, told
Guidewire stock sinks 6.7%: GWRE slides below $190 as traders eye next earnings

Guidewire stock sinks 6.7%: GWRE slides below $190 as traders eye next earnings

New York, January 3, 2026, 20:07 ET — Market closed Shares of Guidewire Software fell 6.7% on Friday to $187.63, after swinging between $187.10 and $202.00 in the session. About 807,000 shares changed hands. The drop matters because Guidewire is a widely followed bet on insurers’ shift to cloud-based core systems, a transition investors have treated as a multi-year growth story. Rate expectations still loom over growth stocks, and sharp moves can follow when investors reassess how much they want to pay for earnings expected further out. For Guidewire, the focus is its shift from license sales to cloud subscriptions.
BILL stock drops 7% to start 2026 as rate jitters hit fintech; KBW lifts target

BILL stock drops 7% to start 2026 as rate jitters hit fintech; KBW lifts target

NEW YORK, January 3, 2026, 20:13 ET — Market closed Shares of BILL Holdings, Inc. fell 7.3% on Friday to $50.56, a sharp drop on the first U.S. trading session of 2026. The decline came as investors leaned toward value stocks and away from growth names while U.S. Treasury yields moved higher. The Dow and S&P 500 ended up on the day, while the Nasdaq dipped, according to Reuters data. Reuters That matters for BILL because the fintech is often priced like a growth software company, which can make it more sensitive to shifts in rate expectations early in the
Polestar stock slides 7% as investors eye Jan. 9 sales update after Geely-backed funding moves

Polestar stock slides 7% as investors eye Jan. 9 sales update after Geely-backed funding moves

New York, Jan 3, 2026, 8:05 PM ET — Market closed Polestar Automotive Holding UK PLC (PSNY) shares fell 7.3% on Friday to $19.81, finishing the last U.S. session lower with markets now shut for the weekend. The drop matters because Polestar is heading into a key data point on demand after a turbulent December that included a 1-for-30 reverse split and fresh funding announcements. Polestar has said it expects to report fourth-quarter retail sales volumes on Jan. 9. Investors have been tracking how quickly the Sweden-based electric-vehicle maker can shore up its balance sheet, after leaning on its majority
AppLovin stock today: APP slides 8% and breaks a key trend line — what traders watch next

AppLovin stock today: APP slides 8% and breaks a key trend line — what traders watch next

NEW YORK, January 3, 2026, 20:17 ET — Market closed AppLovin Corp (NASDAQ: APP) shares fell 8.2% on Friday to $618.32, extending a late-December pullback into the first trading day of 2026. The stock hit about $611 and ended below its 50-day moving average near $639, a closely watched momentum gauge, MarketBeat data showed. The drop marked a seventh straight session of losses since the stock hit an all-time high of $733.60 on Dec. 22, making it the worst performer in the S&P 500 on the day, Barron’s reported. AppLovin gained 108% in 2025, and the retreat has sharpened debate
Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

NEW YORK, January 3, 2026, 20:03 ET — Market closed Liquidia Corp shares ended sharply lower on Friday, retreating about 9% to $31.40 and giving back ground after trading near a fresh 52-week high earlier in the session. The drop matters because it came on the first U.S. trading day of 2026, a period when investors often reset risk and rebalance exposure in small- and mid-cap healthcare names. Liquidia’s move was far larger than the broader biotech tape. Derivatives positioning added to the focus. Options activity flagged unusually heavy demand for bearish protection tied to $30, a strike that sits
CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

NEW YORK, January 3, 2026, 20:10 ET — Market closed CoreWeave, Inc. said it amended a credit agreement tied to its DDTL 3.0 facility, a regulatory filing showed. TradingView Shares of the AI cloud provider closed Friday up 10.77% at $79.32, data showed. Investing The amendment lands as investors weigh how quickly debt-heavy AI infrastructure companies can keep adding capacity without tripping lender safeguards. Covenants — rules inside loan documents that require cash levels or financial ratios — can force a borrower to raise funding or curb spending if it falls short. DDTL stands for delayed-draw term loan, which lets
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

NEW YORK, January 3, 2026, 20:15 ET — Market closed Spyre Therapeutics, Inc. shares fell 6.6% on Friday to $30.58, finishing the first U.S. trading day of 2026 near the lower end of the session’s $30.11-$33.31 range. The stock remains below its 52-week high of $34.49 after trading about 889,000 shares, while biotech benchmarks were little changed. The slide stands out because small-cap biotech names can swing sharply when investors reset positioning at the start of the year, especially after thin holiday liquidity. With little fresh company news since the last quarterly update, traders are leaning more heavily on macro
Klaviyo stock drops nearly 10% as 2026 opens — what KVYO investors watch next

Klaviyo stock drops nearly 10% as 2026 opens — what KVYO investors watch next

NEW YORK, Jan 3, 2026, 19:55 ET — Market closed Shares of Klaviyo (KVYO) closed down 9.7% on Friday at $29.32, marking a sharp slide on the first trading day of 2026. The move matters now because investors began the new year with a fresh rate backdrop: U.S. Treasury yields climbed, and growth stocks lagged as traders recalibrated expectations for Federal Reserve policy and upcoming data. Reuters Klaviyo’s drop also puts attention back on what the company says about 2026 demand and margins when it next reports results, with the earnings date currently estimated for Feb. 18. Nasdaq U.S. stocks

Stock Market Today

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

7 February 2026
New York, Feb 7, 2026, 05:50 EST — Market closed. Exxon Mobil shares ended Friday up 2.03% at $149.05, notching a fresh 52-week high as energy stocks tracked a broad U.S. equity rally into the weekend. (MarketWatch) The setup for next week looks less tidy. Oil has been swinging on U.S.-Iran headlines, and that tends to spill straight into big integrated names like Exxon. Brent settled at $68.05 a barrel on Friday while U.S. West Texas Intermediate (WTI), the U.S. benchmark, finished at $63.55. “We keep going back and forth on this Iran situation,” said John Kilduff, a partner at
Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop